FR3339M - Médicament a base de dérivé du fluorene. - Google Patents

Médicament a base de dérivé du fluorene.

Info

Publication number
FR3339M
FR3339M FR943489A FR943489A FR3339M FR 3339 M FR3339 M FR 3339M FR 943489 A FR943489 A FR 943489A FR 943489 A FR943489 A FR 943489A FR 3339 M FR3339 M FR 3339M
Authority
FR
France
Prior art keywords
based drug
fluorene derivative
fluorene
derivative
drug
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR943489A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ROCAL SOC
Original Assignee
ROCAL SOC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ROCAL SOC filed Critical ROCAL SOC
Priority to FR943489A priority Critical patent/FR3339M/fr
Application granted granted Critical
Publication of FR3339M publication Critical patent/FR3339M/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/06—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom
    • C07D213/16—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom containing only one pyridine ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
FR943489A 1963-08-01 1963-08-01 Médicament a base de dérivé du fluorene. Expired FR3339M (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR943489A FR3339M (fr) 1963-08-01 1963-08-01 Médicament a base de dérivé du fluorene.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR943489A FR3339M (fr) 1963-08-01 1963-08-01 Médicament a base de dérivé du fluorene.

Publications (1)

Publication Number Publication Date
FR3339M true FR3339M (fr) 1965-05-31

Family

ID=8809727

Family Applications (1)

Application Number Title Priority Date Filing Date
FR943489A Expired FR3339M (fr) 1963-08-01 1963-08-01 Médicament a base de dérivé du fluorene.

Country Status (1)

Country Link
FR (1) FR3339M (fr)

Similar Documents

Publication Publication Date Title
FR3111M (fr) Médicament a base de dérivé de cystéine.
FR3522M (fr) Médicament a base de benzamides substitués.
FR2831M (fr) Médicament a base de pancréas.
FR3475M (fr) Médicament a base de diphényl-amino-éthylamine.
FR3456M (fr) Médicament a base de fluoropyrimidines.
FR3202M (fr) Médicament a base de dérivé de théophylline.
FR2239M (fr) Médicaments a base de dialcoyl-aminoalcoyl-pipéridines.
FR3339M (fr) Médicament a base de dérivé du fluorene.
FR3790M (fr) Nouveaux médicaments a base de 2-alkyl-4-alkylamino-6-alkoxy-s-triazines.
FR3822M (fr) Nouveau médicament a base de 1-naphtylacétamides α-substituées.
FR3162M (fr) Médicament a base de sulfapyrimidines.
FR3494M (fr) Médicament a base de 16α-méthyl-stéroides.
FR3512M (fr) Médicaments a base de 1-beta-d-arabinofuranosylcytosine.
FR3543M (fr) Médicaments a base de cétones basiques.
FR2550M (fr) Médicament a action anorexogene a base de phénylhydroxyéthylamines.
FR3774M (fr) Médicament a base de nouvelles oxaza-bicyclo-alcanones.
FR3838M (fr) Médicament anthelmintique a base de 5-arylazorhodanines.
FR2845M (fr) Médicament a base de hypoxanthine-d-ribo-furanoside.
FR2366M (fr) Médicament antiphlogistique a base de ruscogénine.
FR2360M (fr) Médicament antiphlogistique a base de tigogenine.
FR3757M (fr) Médicament a base de streptokinase.
FR3235M (fr) Médicament a base de sulfanilamido-pyrimidine.
FR3033M (fr) Médicaments a base de sulfapyridines.
FR3051M (fr) Médicament a base de dérivé de thiadiazol.
FR3874M (fr) Médicament nouveau a base de mitochondries.